GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Share Price & AI Investment Analysis

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide. In addition, the company offers general medicines,. Track GlaxoSmithKline Pharmaceuticals Limited's live NSE:GLAXO share price ₹2,836.50 (-1.51%), market cap ₹₹481B, P/E 45.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for GLAXO — real-time NSE India stock intelligence.